Catalyst Wire Dossier Catalyst Wire Dossier

Inhaled interferon-β

interferon-β · Synairgen Research Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Inhaled interferon-β, covering 2023-03-27 to 2023-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 [Phase 3]

See pricing